Home > Insider Trading > Filing (0001209191-23-009174)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550395	David Altshuler	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Global Research And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-02-10	3,461	$294.33	65,184	No	4	F	Direct
Common Stock	Disposition	2023-02-13	5,990	$298.26	59,194	No	4	F	Direct
Common Stock	Disposition	2023-02-13	245	$296.44	58,949	No	4	S	Direct
Common Stock	Disposition	2023-02-13	2,160	$298.47	56,789	No	4	S	Direct
Common Stock	Disposition	2023-02-13	1,893	$299.36	54,896	No	4	S	Direct
Common Stock	Disposition	2023-02-13	500	$300.23	54,396	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
Open market sales reported on this line occurred at a weighted average price of $298.47 (range $297.85 to $298.82).
Open market sales reported on this line occurred at a weighted average price of $299.36 (range $298.86 to $299.83).
Open market sales reported on this line occurred at a weighted average price of $300.23 (range $299.96 to $300.63).